Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The global Medical Grade Chitosan revenue was US$ 34 million in 2022 and is forecast to a readjusted size of US$ 58 million by 2029 with a CAGR of 7.8% during the forecast period (2023-2029).
In India, the Medical Grade Chitosan revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
This report focuses on global and India Medical Grade Chitosan market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Medical Grade Chitosan will continue to grow rapidly in the future.
Global Medical Grade Chitosan Scope and Market Size
Medical Grade Chitosan market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Medical Grade Chitosan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Medical Grade Chitosan market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Chapter 1: Introduces Medical Grade Chitosan definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Medical Grade Chitosan companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Medical Grade Chitosan in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8: China by type, by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Grade Chitosan sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: Research findings and conclusion